Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 987-995 , August 1995

Insulin resistance in adipocytes of obese women: Effects of body fat distribution and race

  • Hillary J. Dowling

      Affiliations

    • Obesity Research Center, Department of Medicine, St. Luke's/Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
    • Department of Nutritional Sciences, Cook College, Rutgers University, New Brunswick, NJ, USA
    • ,
  • Susan K. Fried

      Affiliations

    • Obesity Research Center, Department of Medicine, St. Luke's/Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
    • Department of Nutritional Sciences, Cook College, Rutgers University, New Brunswick, NJ, USA
    • ,
  • F.Xavier Pi-Sunyer

      Affiliations

    • Corresponding Author InformationAddress reprint requests to F. Xavier Pi-Sunyer, MD, Director, Obesity Research Center, St. Luke's∥Roosevelt Hospital Center, Woman's Hospital, lOth Floor, Amsterdam Avenue at 114th Street, New York, NY 10025.
    • Obesity Research Center, Department of Medicine, St. Luke's/Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
    • Department of Nutritional Sciences, Cook College, Rutgers University, New Brunswick, NJ, USA

Received 26 May 1994 ,Accepted 31 October 1994.

References 

  1. Krotkiewski M, Bjorntorp P, Sjostrom L, et al.  Impact of obesity on metabolism in men and women: Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150–1162
  2. Kissebah AH, Vydelingum N, Murray R, et al.  Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254–260
  3. Kissebah AH, Peiris AN, Evans DJ. Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: Window with a view. Acta Med Scand. 1988;723:79–90
  4. Lapidus L, Bengtsson C, Larsson B, et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 1984;289:1257–1261
  5. Lapidus L, Bengtsson C. Regional obesity as a health hazard in women: Prospective studies. Acta Med Scand. 1988;723:53–61
  6. Dowling HJ, Pi-Sunyer FX. Race-dependent health risks of upper body obesity. Diabetes. 1993;42:537–543
  7. Stevens J, Keil JE, Rust PF, et al.  Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med. 1992;152:1257–1262
  8. Banerji MA, Lebovitz HE. Coronary heart disease risk factor profiles in black patients with non—insulin-dependent diabetes mellitus: Paradoxic patterns. Am J Med. 1991;91:51–58
  9. Dawson DA. Ethnic differences in female overweight: Data from the 1985 National Health Interview Survey. Am J Pub Health. 1988;78:1326–1329
  10. Kumanyika S. Obesity in black women. Epidemiol Rev. 1987;9:31–50
  11. Wing RR, Kuller LH, Bunker C, et al.  Obesity, obesityrelated behaviors and coronary heart disease risk factors in black and white premenopausal women. Int J Obes. 1989;13:511–519
  12. Evans DJ, Murray R, Kissebah AH. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding: Effects of obesity and body fat topography. J Clin Invest. 1984;74:1515–1525
  13. Peiris AN, Mueller RA, Smith GA, et al.  Splanchnic insulin metabolism in obesity: Influence of body fat distribution. J Clin Invest. 1986;78:1648–1657
  14. Jensen MD, Haymond MW, Rizza RA, et al.  Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168–1173
  15. Bjorntorp P. Abdominal obesity and the development of non—insulin dependent diabetes mellitus. Diabetes Metab Rev. 1988;4:615–622
  16. Smith U, Hammersten J, Bjorntorp P, et al.  Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest. 1979;9:327–332
  17. Arner P, Hellstrom L, Wahrenberg H, et al.  Betaadrenoreceptor expression in human fat cells from different regions. J Clin Invest. 1990;86:1595–1600
  18. Wahrenberg H, Lonnqvist F, Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest. 1989;84:458–467
  19. Bolinder J, Engfeldt P, Ostman J. Site differences in the insulin receptor binding and insulin action in subcutaneous fat of obese women. J Clin Endocrinol Metab. 1983;57:455–461
  20. Arner P, Bolinder J, Engfeldt P. The anti-lipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia and starvation. Metabolism. 1981;30:753–760
  21. Landin K, Lonnroth P, Krotkiewski M. Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio. Eur J Clin Invest. 1990;20:530–535
  22. Ortiz O, Russell M, Daley TL, et al.  Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition. Am J Clin Nutr. 1992;55:8–13
  23. Kashiwagi A, Bogardus C, Lillioja S. In vitro insensitivity of glucose transport and anti-lipolysis to insulin due to receptor and post-receptor abnormalities in obese Pima Indians with normal glucose tolerance. Metabolism. 1984;33:772–777
  24. Digirolamo M, Mendlinger S, Fertig JW. A simple method to determine fat cell size and number in four mammalian species. Am J Physiol. 1971;221:850–858
  25. Goldrick RB. Morphological changes in the adipocyte during fat deposition and mobilization. Am J Physiol. 1967;212:777–782
  26. Zinder O, Shapiro B. Effect of cell size on epinephrine and ACTH-induced fatty acid release from isolated fat cells. J Lipid Res. 1971;12:91–95
  27. Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956;35:150–154
  28. Berlan M, Lafontan M. Evidence that epinephrine acts preferentially as an anti-lipolytic agent in abdominal human subcutaneous fat cells: Assessment by analysis of beta and alpha2 adrenoreceptor properties. Eur J Clin Invest. 1985;15:341–348
  29. Kather H, Bieger W, Michel G, et al.  Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest. 1985;76:1559–1565
  30. Boobis LH, Maughan RJ. A simplified one-step enzymatic fluorimetric method for determination of glycerol in 20 uL of plasma. Clin Chim Acta. 1983;132:173–179
  31. Winer BJ. Design and analysis of single-factor experiments, in Statistical Principles in Experimental Design. In: New York, NY: McGraw-Hill; 1971;p. 198–201
  32. Kather H. Purine accumulation in human fat cell suspensions. J Biol Chem. 1988;263:8803–8809
  33. Yki-Jarvinen H, Taskinen MR. Inter-relationships among insulin's anti-lipolytic and glucoregulatory effects and plasma triglycerides in non-diabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes. 1988;37:1271–1278
  34. Cavallo-Perin P, Bruno A, Cassader M, et al.  The glucoregulatory and anti-lipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: An in vivo and in vitro study. Eur J Clin Invest. 1992;22:725–731
  35. Yki-Jarvinen H, Kubo K, Zawadzki J, et al.  Dissociation of in vitro sensitivities of glucose transport and anti-lipolysis to insulin in NIDDM. Am J Physiol. 1987;253:E300–E304
  36. Garvey W, Huecksteadt TP, Matthaei S, et al.  Role of glucose transporters in the cellular insulin resistance of type II non—insulin-dependent diabetes mellitus. J Clin Invest. 1988;81:1528–1536
  37. Kashiwagi A, Verso MA, Andrews J, et al.  In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin dependent diabetes mellitus. J Clin Invest. 1983;72:1246–1254
  38. Bolinder J, Kager L, Ostman J. Differences at the receptor and post-receptor levels between human omental and subcutaneous adipose tissue. Diabetes. 1983;32:117–123
  39. Richelsen B, Pedersen SB, Moller-Pedersen T, et al.  Regional differences in triglyceride breakdown in human adipose tissue: Effects of catecholamines, insulin and prostaglandin E2. Metabolism. 1991;40:990–996
  40. Manganiello VC, Smith CJ, Degerman E. Molecular mechanisms involved in the antilipolytic action of insulin: Phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase. Adv Exp Med Biol. 1991;293:239–248
  41. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest. 1991;88:609–613
  42. Wesslau C, Erikson JW, Smith U. Cellular cyclic AMP levels modulate insulin sensitivity; responsiveness—evidence against a significant role of Gi's in insulin signal transduction. Biochem Biophys Res Commun. 1993;196:287–293
  43. Conway JM, Yanovski SZ, Aviland NA, et al.  Adipose tissue changes during weight loss in black and white females. FASEB J. 1993;1629; (abstr)

☆ Supported by grants from the National Institutes of Health (DK-40414 and 5T32-DK-07559-02) and the Weight Watchers Foundation.

PII: 0026-0495(95)90094-2

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 987-995 , August 1995

Article Tools